Home > News > Starpharma: Human Trials of Anti-HIV Product
July 31st, 2003
Starpharma: Human Trials of Anti-HIV Product
Abstract:
Melbourne biotech company Starpharma Pooled Development Ltd has received FDA clearance to proceed with human clinical trials of its new dendrimer nano-drug VivaGel. The gel will be used as a preventative against the transmission of HIV during sexual intercourse. It has been highly successful in preventing infection in monkey trials using a humanised strain of simian immunodeficiency virus.
Source:
Starpharma
Bookmark:
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||